Patents by Inventor Jeffrey Kovac

Jeffrey Kovac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240136983
    Abstract: A scalable periphery tunable matching power amplifier is presented. Varying power levels can be accommodated by selectively activating or deactivating unit cells of which the scalable periphery tunable matching power amplifier is comprised. Tunable matching allows individual unit cells to see a constant output impedance, reducing need for transforming a low impedance up to a system impedance and attendant power loss. The scalable periphery tunable matching power amplifier can also be tuned for different operating conditions such as different frequencies of operation or different modes.
    Type: Application
    Filed: October 24, 2023
    Publication date: April 25, 2024
    Inventors: Dan William Nobbe, David Halchin, Jeffrey A. Dykstra, Michael P. Gaynor, David Kovac, Kelly Michael Mekechuk, Gary Frederick Kaatz, Chris Olson
  • Patent number: 11786500
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: October 17, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Timothy Heffernan, Jeffrey Kovacs, Nakia Spencer, Christopher Bristow
  • Publication number: 20220016069
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Application
    Filed: May 21, 2021
    Publication date: January 20, 2022
    Inventors: Timothy HEFFERNAN, Jeffrey KOVACS, Nakia SPENCER, Christopher BRISTOW
  • Patent number: 11045443
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: June 29, 2021
    Assignee: Board of Regents, The University of Texas System
    Inventors: Timothy Heffernan, Jeffrey Kovacs, Nakia Spencer, Christopher Bristow
  • Publication number: 20200368196
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Application
    Filed: June 3, 2020
    Publication date: November 26, 2020
    Inventors: Timothy HEFFERNAN, Jeffrey KOVACS, Nakia SPENCER, Christopher BRISTOW
  • Patent number: 10722487
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: July 28, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Timothy Heffernan, Jeffrey Kovacs, Nakia Spencer, Christopher Bristow
  • Publication number: 20190274993
    Abstract: Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.
    Type: Application
    Filed: October 18, 2018
    Publication date: September 12, 2019
    Inventors: Timothy HEFFERNAN, Jeffrey KOVACS, Nakia SPENCER, Christopher BRISTOW
  • Publication number: 20190134032
    Abstract: Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject.
    Type: Application
    Filed: August 22, 2018
    Publication date: May 9, 2019
    Inventors: Timothy P. HEFFERNAN, Carlo TONIATTI, Jeffrey KOVACS, Virginia GIULIANI, Nakia SPENCER, Maria Emilia DI FRANCESCO, Christopher A. BRISTOW
  • Publication number: 20160058759
    Abstract: Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject.
    Type: Application
    Filed: July 3, 2015
    Publication date: March 3, 2016
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Timothy P. Heffernan, Carlo Toniatti, Jeffrey Kovacs, Virginia Giuliani, Nakia Spence, Maria Emilia Di Francesco, Christopher A. Bristow
  • Publication number: 20070207950
    Abstract: The present invention provides methods and compositions for inhibiting Hsp90 activity in a cell, comprising contacting the cell with an inhibitor of histone deacetylase 6 (HDAC6)
    Type: Application
    Filed: December 21, 2006
    Publication date: September 6, 2007
    Inventors: Tso-Pang Yao, Jeffrey Kovacs, Charlotte Hubbert, Yi-shan Lee, Ya-sheng Gao, June-Tai Wu
  • Publication number: 20060198707
    Abstract: An insert retention screw comprises a head with a radius that is a sufficient size to fit within a mounting hole of a cutting insert and seat within a seating plane within the mounting hole that is generally perpendicular to the axis of the insert when the screw is at an angle in a range of about 0-15 degrees. The retention screw is provided for holding a cutting insert in the pocket of a tool body. The pocket is partially defined by a floor and a seating surface. A threaded hole is at an angle that is taken with reference to the pocket floor. The insert has a mounting hole passing therethrough. The retention screw passes through the mounting hole and threads into the threaded hole so as to draw the insert against the seating surface.
    Type: Application
    Filed: May 3, 2006
    Publication date: September 7, 2006
    Inventors: Glenn Sheffler, Jeffrey Kovac, Kevin Gamble, Karen Craig